A Newcastle medtech company has secured nearly £250,000 in funding from Innovate UK to further its research into the impact of genetics on implants.
Based in The Biosphere on Newcastle Helix, ExplantLab combines extensive medical, bioengineering and surgical knowledge to further understand explants (implants that have been removed from the body). Having opened last year with both chemistry and biology laboratories, The Biosphere is already close to 50 per cent full and is home to a host of innovative life sciences companies.